Association between cardiac function and metabolic factors including adiponectin in patients with acute myocardial infarction

Journal of Cardiology

Volumn 53, Issue 1, 2009, Pages 65-71

  Kimura, Kumi ^a   Miura, Shin ichiro ^a   Iwata, Atsushi ^a   Sugihara, Makoto ^a   Arimura, Tadaaki ^a   Nishikawa, Hiroaki ^a   Kawamura, Akira ^a   Saku, Keijiro ^a  

^a FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Acute myocardial infarction; Adiponectin; Brain natriuretic peptide; Cardiac remodeling

Indexed keywords

ADIPONECTIN; BRAIN NATRIURETIC PEPTIDE; CREATINE KINASE; HEMOGLOBIN A1C; LIPID;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY STENT; DIABETES MELLITUS; DYSLIPIDEMIA; ECHOCARDIOGRAPHY; FEMALE; HEART FUNCTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC PARAMETERS; PROTEIN BLOOD LEVEL;

ADIPONECTIN; AGED; ECHOCARDIOGRAPHY; FEMALE; HEART; HUMANS; MALE; MYOCARDIAL INFARCTION; NATRIURETIC PEPTIDE, BRAIN; REGRESSION ANALYSIS; VENTRICULAR REMODELING;

EID: 58249136921     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.08.012     Document Type: Article

References (28)

1. Lakka H.M., Laaksonen D.E., Lakka T.A., Niskanen L.K., Kumpusalo E., Tuomilehto J., et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288 (2002) 2709-2716
2. Nakamura Y., Shimada K., Fukuda D., Shimada Y., Ehara S., Hirose M., et al. Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90 (2004) 528-533
3. Otsuka F., Sugiyama S., Kojima S., Maruyoshi H., Funahashi T., Matsui K., et al. Plasma adiponectin levels are associated with coronary lesion complexity in men with coronary artery disease. J Am Coll Cardiol 48 (2006) 1155-1162
4. Kenchaiah S., Evans J.C., Levy D., Wilson P.W., Benjamin E.J., Larson M.G., et al. Obesity and the risk of heart failure. N Engl J Med 347 (2002) 305-313
5. Lavie C.J., Osman A.F., Milani R.V., and Mehra M.R. Body composition and prognosis in chronic systolic heart failure: the obesity paradox. Am J Cardiol 91 (2003) 891-894
6. Horwich T.B., and Fonarow G.C. The impact of obesity on survival in patients with heart failure. Heart Fail Monit 3 (2002) 8-14
7. Kistorp C., Faber J., Galatius S., Gustafsson F., Frystyk J., Flyvbjerg A., et al. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure. Circulation 112 (2005) 1756-1762
8. Nakamura T., Funayama H., Kubo N., Yasu T., Kawakami M., Saito M., et al. Association of hyperadiponectinemia with severity of ventricular dysfunction in congestive heart failure. Circ J 70 (2006) 1557-1562
9. Shibata R., Izumiya Y., Sato K., Papanicolaou K., Kihara S., Colucci W.S., et al. Adiponectin protects against the development of systolic dysfunction following myocardial infarction. J Mol Cell Cardiol 42 (2007) 1065-1074
10. Devereux R.B. Detection of left ventricular hypertrophy by M-mode echocardiography. Hypertension 9 Suppl. II (1987) 19-26
11. Kojima S., Funahashi T., Otsuka F., Maruyoshi H., Yamashita T., Kajiwara I., et al. Future adverse cardiac events can be predicted by persistently low plasma adiponectin concentrations in men and marked reductions of adiponectin in women after acute myocardial infarction. Atherosclerosis 194 (2007) 204-213
12. Ouchi N., Kihara S., Funahashi T., Nakamura T., Nishida M., Kumada M., et al. Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue. Circulation 107 (2003) 671-674
13. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., et al. Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257 (1999) 79-83
14. Lauer M.S., Anderson K.M., Kannel W.B., and Levy D. The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study. JAMA 266 (1991) 231-236
15. Shibata R., Ouchi N., Ito M., Kihara S., Shiojima I., Pimentel D.R., et al. Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med 10 (2004) 1384-1389
16. Shibata R., Sato K., Pimentel D.R., Takemura Y., Kihara S., Ohashi K., et al. Adiponectin protects against myocardial ischemia-reperfusion injury through AMPK- and COX-2-dependent mechanisms. Nat Med 11 (2005) 1096-1103
17. Inoue T., Kotooka N., Morooka T., Komoda H., Uchida T., Aso Y., et al. High molecular weight adiponectin as a predictor of long-term clinical outcome in patients with coronary artery disease. Am J Cardiol 100 (2007) 569-574
18. Liao Y., Takashima S., Maeda N., Ouchi N., Komamura K., Shimomura I., et al. Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism. Cardiovasc Res 67 (2005) 705-713
19. MacLellan W.R., and Schneider M.D. Death by design. Programmed cell death in cardiovascular biology and disease. Circ Res 81 (1997) 137-144
20. Sam F., Sawyer D.B., Chang D.L., Eberli F.R., Ngoy S., Jain M., et al. Progressive left ventricular remodeling and apoptosis late after myocardial infarction in mouse heart. Am J Physiol: Heart Circ Physiol 279 (2000) H422-H428
21. Tao L., Gao E., Jiao X., Yuan Y., Li S., Christopher T.A., et al. Adiponectin cardioprotection after myocardial ischemia/reperfusion involves the reduction of oxidative/nitrative stress. Circulation 115 (2007) 1408-1416
22. Sengenes C., Stich V., Berlan M., Hejnova J., Lafontan M., Pariskova Z., et al. Increased lipolysis in adipose tissue and lipid mobilization to natriuretic peptides during low-calorie diet in obese women. Int J Obes Relat Metab Disord 26 (2002) 24-32
23. Iwata A., Miura S., Nishikawa H., Kawamura A., Matsuo Y., Sako H., et al. Significance of combined angiotensin II receptor blocker and carvedilol therapy in patients with congestive heart failure and arginine variant. J Cardiol 47 (2006) 1-7
24. Sugiyama S., Fukushima H., Kugiyama K., Maruyoshi H., Kojima S., Funahashi T., et al. Pravastatin improved glucose metabolism associated with increasing plasma adiponectin in patients with impaired glucose tolerance and coronary artery disease. Atherosclerosis 194 (2007) e43-e51
25. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., et al. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
26. Pischon T., Girman C.J., Hotamisligil G.S., Rifai N., Hu F.B., and Rimm E.B. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA 291 (2004) 1730-1737
27. Levine B., Kalman J., Mayer L., Fillit H.M., and Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 323 (1990) 236-241
28. Yamauchi T., Kamon J., Minokoshi Y., Ito Y., Waki H., Uchida S., et al. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8 (2002) 1288-1295